Genetic Toxicology CROs for Dog Studies

5 contract research organizations in our directory list both Genetic Toxicology and Dog among their capabilities, across 4 countries. 5 report GLP capability and 1 reports AAALAC accreditation. Confirm species-specific experience with each lab when you get in touch.

5 CROs 5 GLP 1 AAALAC 4 countries

Genetic Toxicology CROs for Dog Studies

Showing 5 CROs. Order rotates daily so no lab is permanently listed first.

Eurofins Advinus

IN GLP

Bengaluru-based preclinical CRO, part of Eurofins, offering GLP safety assessment, DMPK and discovery services for pharmaceutical and agrochemical sponsors.

Genetic Toxicology GLP Toxicology Pharmacokinetics Repeat-Dose Toxicity Reproductive Toxicity Dog Mouse Rabbit Rat

Research Toxicology Centre (RTC)

IT GLP

Italian GLP CRO near Rome providing regulatory toxicology and safety studies for pharmaceuticals, chemicals and agrochemicals.

Genetic Toxicology GLP Toxicology Repeat-Dose Toxicity Reproductive Toxicity Dog Mouse Rabbit Rat

Biotoxtech

KR GLP AAALAC

Korean non-clinical CRO offering IND and NDA-enabling GLP toxicology, including general, reproductive and genetic toxicity, carcinogenicity and safety pharmacology, with NHP capacity through its group companies.

Genetic Toxicology Carcinogenicity Studies GLP Toxicology Repeat-Dose Toxicity Reproductive Toxicity Dog Mouse Non-human Primate Rabbit

Toxi-Coop

HU GLP

Hungarian non-clinical CRO founded in 1982 offering GLP general, genetic and reproductive toxicology for pharmaceutical, chemical and agrochemical sponsors.

Genetic Toxicology Acute Toxicity GLP Toxicology Reproductive Toxicity Dog Mouse Rabbit Rat

Jai Research Foundation (JRF)

IN GLP

Indian GLP CRO providing regulatory toxicology and safety studies for pharmaceuticals, agrochemicals, chemicals and biologics.

Genetic Toxicology GLP Toxicology Repeat-Dose Toxicity Reproductive Toxicity Toxicology Dog Mouse Rabbit Rat

Questions to ask when choosing a Genetic Toxicology in Dog CRO

  • Are your Ames, in vitro micronucleus and in vivo micronucleus assays run under GLP, and when was your last inspection?
  • Can the in vivo micronucleus or comet endpoint be integrated into our rodent repeat-dose study?
  • What historical negative and positive control data do you hold for each assay?
  • How do you handle compounds that are cytotoxic or poorly soluble at the top concentration?
  • Do you offer non-GLP screening versions of these assays for lead optimization?